[
    {
        "id": "osp-11622",
        "type": "article-journal",
        "title": "Graves’ Disease following Interferon Therapy for Chronic Hepatitis C Infection",
        "author": [
            {
                "family": "Elshafie",
                "given": "Omayma"
            },
            {
                "family": "Hussein",
                "given": "Samir"
            },
            {
                "family": "Woodhouse",
                "given": "Waheed"
            },
            {
                "family": "Nicholas",
                "given": ""
            }
        ],
        "URL": "https://omanscience.com/ar/articles/graves-disease-following-interferon-therapy-for-chronic-hepatitis-c-infection",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2025
                ]
            ]
        },
        "container-title": "Sultan Qaboos University Medical Journal",
        "volume": "8",
        "issue": "1",
        "page": "75-77",
        "DOI": "10.18295/2075-0528.2697",
        "publisher": "Sultan Qaboos University",
        "ISSN": "2075-051X",
        "abstract": "We describe the first case of Graves’ disease occurring at Sultan Qaboos University Hospital, Oman, in a patient who was under treatment with interferon alfa for HCV infection. INF-α is now being widely used to treat patients with a variety of disorders including infection with hepatitis C virus. Clinical thyroid disease, hypo and hyperthyroidism can occur in up to 15% of patients. We emphasize the need for thyroid function screening before and during therapy to identify patients early in the course of their disease."
    }
]